Showing results (51-60 of 59) with videos related to

Sort By:
Pageof 6
You have reached the last page of results.This site can display upto 59 results.
Pharmacoeconomics|September 14, 2010
Comparative effectiveness without head-to-head trials: a method for matching-adjusted indirect comparisons applied to psoriasis treatment with adalimumab or etanerceptJames E Signorovitch, Eric Q Wu, Andrew P Yu, et al.
Diabetes Research and Clinical Practice|November 10, 2009
Direct costs associated with initiating NPH insulin versus glargine in patients with type 2 diabetes: a retrospective database analysisLauren J Lee, Andrew P Yu, Scott J Johnson, et al.
American Journal of Cardiovascular Drugs : Drugs, Devices, and Other Interventions|December 15, 2010
Compliance, persistence, healthcare resource use, and treatment costs associated with aliskiren plus ARB versus ACE inhibitor plus ARB combination therapy: in US patients with hypertensionJoanne Chang, Weiyi Yang, Kristijan H Kahler, et al.
Journal of Medical Economics|March 31, 2011
Copayment level, treatment persistence, and healthcare utilization in hypertension patients treated with single-pill combination therapyWeiyi Yang, Kristijan H Kahler, Thomas Fellers, et al.
The American Journal of Managed Care|December 11, 2008
Adherence to inhaled corticosteroid use and local adverse events in persistent asthmaJasmina I Ivanova, Howard G Birnbaum, Matthew Hsieh, et al.
The American Journal of Gastroenterology|October 16, 2008
Effects of adalimumab maintenance therapy on health-related quality of life of patients with Crohn's disease: patient-reported outcomes of the CHARM trialEdward V Loftus, Brian G Feagan, Jean-Frédéric Colombel, et al.
American Journal of Clinical Dermatology|November 30, 2010
Efficacy and safety of adalimumab among patients with moderate to severe psoriasis with co-morbidities: Subanalysis of results from a randomized, double-blind, placebo-controlled, phase III trialAlexa B Kimball, Arielle G Bensimon, Annie Guerin, et al.
The American Journal of Gastroenterology|April 9, 2009
Comparison of two adalimumab treatment schedule strategies for moderate-to-severe Crohn's disease: results from the CHARM trialJean-Frédéric Colombel, William J Sandborn, Paul Rutgeerts, et al.
Gastroenterology|October 14, 2008
Effects of adalimumab therapy on incidence of hospitalization and surgery in Crohn's disease: results from the CHARM studyBrian G Feagan, Remo Panaccione, William J Sandborn, et al.
Pageof 6